Coronavirus Disease 2019 Convalescent Plasma Utilization in the United States: Data from the National Inpatient Sample
Date:
07/26/2023
Locations:
Topics:
Citation:
Bloch EM, Goel R, Zhu X, Patel EU, Shoham S, Sullivan DJ, Gebo KA, Casadevall A, Tobian AAR. Coronavirus Disease 2019 Convalescent Plasma Utilization in the United States: Data From the National Inpatient Sample. Clin Infect Dis. 2023 Jul 26;77(2):237-241. doi: 10.1093/cid/ciad185. PMID: 36987595; PMCID: PMC10371309.
Abstract
Coronavirus disease 2019 (COVID-19) convalescent plasma (CCP) use between October and December 2020 was characterized using the National Inpatient Sample database. CCP was administered in 18.0% of COVID-19-associated hospitalizations and was strongly associated with older age and increased disease severity. There were disparities in the receipt of CCP by race and ethnicity, geography, and insurance.